Mrowietz, U; Sommer, R; Reguiai, Z; Gerdes, S; Dauden, E; Weger, W; Maul, JT; Laws, P; Naldi, L; Ghislain, PD; de Jong, E; Mburu, S; Koscielny, V; Massana, E; Kasujee, I; Kirsch, A; Augustin, M.
High Efficacy of Tildrakizumab in biologic-naive and biologic-experienced Patients with moderate to severe Psoriasis: 52-week Results from the POSITIVE Study
J DTSCH DERMATOL GES. 2025; 23: 85-86.
Web of Science